TerrAscend Corp. (TSNDF) Financials
TSNDF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 549.1 million | 458.2 million |
| Dec. 31, 2025 | 557.4 million | 458.4 million |
| Sept. 30, 2025 | 555.3 million | 459.8 million |
| June 30, 2025 | 572.0 million | 453.6 million |
TSNDF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 7.6 million | 885000 |
| Dec. 31, 2025 | 6.4 million | 1.3 million |
| Sept. 30, 2025 | 613276 | 1.4 million |
| June 30, 2025 | 625000 | 779000 |
TSNDF Net Income
No data available :(
TSNDF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 39.6 million | 212.7 million | 29.6 million |
| Dec. 31, 2025 | 37.8 million | 210.7 million | 30.1 million |
| Sept. 30, 2025 | 37.5 million | 211.9 million | 31.8 million |
| June 30, 2025 | 26.7 million | 199.1 million | 32.3 million |
TSNDF Shares Outstanding
TSNDF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 853016 | - | 21.5 million | - |
| Dec. 31, 2025 | 1.7 million | - | 28.0 million | 16.4 million |
| Sept. 30, 2025 | 3.1 million | - | 21.3 million | - |
| June 30, 2025 | 2.2 million | - | 21.0 million | - |
TSNDF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 64.6 million | 30.9 million |
| Dec. 31, 2025 | 59.5 million | 27.1 million |
| Sept. 30, 2025 | 65.1 million | 31.2 million |
| June 30, 2025 | 65.0 million | 31.8 million |
TSNDF
Price: $0.75
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.04 USD
P/E Ratio: 15.88
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 264.8 million